The global Huntington's disease treatment market size reached US$ 491.1 Million in 2023. Looking forward, the market is projected to reach US$ 2.24 billion by 2032, exhibiting a growth rate (CAGR) of 18.41% during 2023-2032. The rising incidences of Huntington’s disease, the increasing demand for advanced drugs for the disease treatment, and recent development of innovative therapeutic approaches represent some of the key factors driving the market.
Huntington's disease refers to a fatal neurodegenerative disorder that causes the progressive breakdown of nerve cells in the brain. Its symptoms include various movement, psychiatric, and cognitive impairments, such as involuntary jerking, muscle problems, difficulty in organizing and focusing, lack of awareness, insomnia, and social withdrawal. Huntington's disease treatment involves the application of various drugs, such as antipsychotics, antidepressants, antiparkinsonians, and mood-stabilizing drugs.
The treatment process also includes various therapies, such as speech, occupational, physical, and psychotherapy. Huntington's disease treatment helps in minimizing the symptoms of movement and psychiatric disorders, assists patients in adapting to new abilities in a shorter time, and develops coping strategies. It also aids in improving everyday tasks, speech, maintaining posture and balance, and enhancing the quality of life.
In line with this, the rapid development of new disease-modifying drugs owing to the improved understanding of the disease, and its underlying causes are acting as another growth-inducing factor. Additionally, the recent development of the innovative therapeutic approach that deters the growth of Huntington's disease by reducing mutant huntingtin (mTT) production levels is positively influencing the market. Apart from this, the introduction of antisense technology that uses antisense oligonucleotides (ASOs) to target huntingtin (HTT) messenger ribonucleic acid (mRNA) and its protein throughout the central nervous system (CNS) is propelling the market growth.
Moreover, increasing initiatives by several governments to promote the development of novel drugs are favoring the market growth. Other factors, including rising awareness among the masses regarding Huntington's disease, significant growth in the healthcare industry, increasing investment in research and development (R&D) activities, rising geriatric population, and escalating demand for off-label medications, are anticipated to drive the market growth.
According to the report, North America was the largest market for Huntington's disease treatment. Some of the factors driving the North America Huntington's disease treatment market includes significant technological advancements, the rapid development of healthcare infrastructure, and the rising number of individuals suffering from Huntington's disease.
2. What is the expected growth rate of the global Huntington’s disease treatment market during 2024-2032?
3. What are the key factors driving the global Huntington’s disease treatment market?
4. What has been the impact of COVID-19 on the global Huntington’s disease treatment market?
5. What is the breakup of the global Huntington’s disease treatment market based on the type?
6. What is the breakup of the global Huntington’s disease treatment market based on the drug type?
7. What is the breakup of the global Huntington’s disease treatment market based on the age?
8. What is the breakup of the global Huntington’s disease treatment market based on the distribution channel?
9. What are the key regions in the global Huntington’s disease treatment market?
10. Who are the key players/companies in the global Huntington’s disease treatment market?
Huntington's disease refers to a fatal neurodegenerative disorder that causes the progressive breakdown of nerve cells in the brain. Its symptoms include various movement, psychiatric, and cognitive impairments, such as involuntary jerking, muscle problems, difficulty in organizing and focusing, lack of awareness, insomnia, and social withdrawal. Huntington's disease treatment involves the application of various drugs, such as antipsychotics, antidepressants, antiparkinsonians, and mood-stabilizing drugs.
The treatment process also includes various therapies, such as speech, occupational, physical, and psychotherapy. Huntington's disease treatment helps in minimizing the symptoms of movement and psychiatric disorders, assists patients in adapting to new abilities in a shorter time, and develops coping strategies. It also aids in improving everyday tasks, speech, maintaining posture and balance, and enhancing the quality of life.
Huntington's Disease Treatment Market Trends
The rising incidence of Huntington's disease across the globe is one of the primary factors driving the market growth. Huntington's disease treatment is widely used to suppress involuntary jerking and writhing movement, treat chorea, reduce violent outbursts and agitation, and enhance strength, flexibility, balance, and coordination, which, in turn, improves the quality of life and enhances the patient's ability to carry out daily routine tasks, such as eating, communications, and walking. Furthermore, the increasing demand for advanced drugs to control the motor, cognitive, and psychiatric symptoms associated with Huntington's disease is providing an impetus to the market growth.In line with this, the rapid development of new disease-modifying drugs owing to the improved understanding of the disease, and its underlying causes are acting as another growth-inducing factor. Additionally, the recent development of the innovative therapeutic approach that deters the growth of Huntington's disease by reducing mutant huntingtin (mTT) production levels is positively influencing the market. Apart from this, the introduction of antisense technology that uses antisense oligonucleotides (ASOs) to target huntingtin (HTT) messenger ribonucleic acid (mRNA) and its protein throughout the central nervous system (CNS) is propelling the market growth.
Moreover, increasing initiatives by several governments to promote the development of novel drugs are favoring the market growth. Other factors, including rising awareness among the masses regarding Huntington's disease, significant growth in the healthcare industry, increasing investment in research and development (R&D) activities, rising geriatric population, and escalating demand for off-label medications, are anticipated to drive the market growth.
Key Market Segmentation
This report provides an analysis of the key trends in each segment of the global Huntington's disease treatment market report, along with forecasts at the global, regional and country level from 2024-2032. The report has categorized the market based on type, drug type, age, distribution channel, and end user.Type Insights:
- Symptomatic Treatment
- Disease-modifying Therapies
Drug Type Insights:
- Approved Drugs
- Tetrabenazine
- Deutetrabenazine
- Off-label Drugs
Age Insights:
- Below 50 Years
- Above 50 Years
Distribution Channel Insights:
- Drug Stores and Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
End User Insights:
- Hospitals
- Homecare
- Specialty Clinics
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
According to the report, North America was the largest market for Huntington's disease treatment. Some of the factors driving the North America Huntington's disease treatment market includes significant technological advancements, the rapid development of healthcare infrastructure, and the rising number of individuals suffering from Huntington's disease.
Competitive Landscape
The report has also provided a comprehensive analysis of the competitive landscape in the global Huntington's disease treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AOP Health, Apotex Inc., Dr. Reddy’s Laboratories Ltd., H. Lundbeck A/S, Hikma Pharmaceuticals PLC, Lupin Limited, Prilenia Therapeutics, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Vaccinex Inc. etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.Key Questions Answered in This Report
1. What was the size of the global Huntington’s disease treatment market in 2023?2. What is the expected growth rate of the global Huntington’s disease treatment market during 2024-2032?
3. What are the key factors driving the global Huntington’s disease treatment market?
4. What has been the impact of COVID-19 on the global Huntington’s disease treatment market?
5. What is the breakup of the global Huntington’s disease treatment market based on the type?
6. What is the breakup of the global Huntington’s disease treatment market based on the drug type?
7. What is the breakup of the global Huntington’s disease treatment market based on the age?
8. What is the breakup of the global Huntington’s disease treatment market based on the distribution channel?
9. What are the key regions in the global Huntington’s disease treatment market?
10. Who are the key players/companies in the global Huntington’s disease treatment market?
Table of Contents
1 Preface3 Executive Summary13 Value Chain Analysis15 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Huntington's Disease Treatment Market
6 Market Breakup by Type
7 Market Breakup by Drug Type
8 Market Breakup by Age
9 Market Breakup by Distribution Channel
10 Market Breakup by End User
11 Market Breakup by Region
12 Drivers, Restraints, and Opportunities
14 Porters Five Forces Analysis
16 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- AOP Health
- Apotex Inc.
- Dr. Reddy’s Laboratories Ltd.
- H. Lundbeck A/S
- Hikma Pharmaceuticals PLC
- Lupin Limited
- Prilenia Therapeutics
- Sun Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Ltd.
- Vaccinex Inc. etc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 135 |
| Published | April 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 491.1 Million |
| Forecasted Market Value ( USD | $ 2240 Million |
| Compound Annual Growth Rate | 18.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
